and counseling to support self-care, medication regimen management including adherence assessment, delivery by multidisciplinary personnel, face-to-face and telephone communication, and high complexity (multiple contacts for multiple visits).
We designed this study to examine secular trends in HF outcomes in Alberta during the past decade, with particular attention to the impact of the ACA initiative on patientrelevant outcomes highlighted by the AHA Get With the Guidelines-Heart Failure project, The Joint Commission, and the Canadian Cardiovascular Society. 3, 8, 9 Methods Setting The province of Alberta has a single payer, government-funded health care system that provides universal access to more than 3.7 million people for hospital, emergency department, and physician services, and the Alberta Health administrative databases thus capture all interactions with the health care system in the province for conditions such as HF. This study received ethics approval from the Health Ethics Research Board at the University of Alberta.
Data Sources
This study used deidentified linked data from 4 Alberta Health administrative databases: (1) the Discharge Abstract Database, which records the admission and discharge dates, most responsible diagnosis (ie, the diagnosis identified by the attending physician at time of discharge as the primary diagnosis which caused the hospitalization), and up to 25 other diagnoses for all acute care hospitalizations; (2) the Ambulatory Care Database, which records all patient visits to hospital-based specialized clinics or Emergency Departments with coding for up to 10 conditions; (3) the Health Practitioner Claims Database, which tracks all physician claims for services and includes up to 3 diagnoses per outpatient encounter; and (4) the Alberta Health Care Insurance Plan Registry, which tracks vital status of all Albertans.
Study Cohort
We identified all adult Albertans hospitalized between April 1, 1999, and December 31, 2009 , with a most responsible diagnosis of HF (International Classification of Diseases [ICD]-9-CM code 428.x from 1999-2002 or ICD-10 code I50.x after 2002-when Alberta switched from ICD-9 to ICD-10). 10, 11 These ICD codes in the Alberta Health databases have previously been shown to have high specificity (97%-99%) and positive predictive value (91%-94%) for HF, when validated against chart audit in Alberta in the same time frame. 10 In our primary analysis, we treated each calendar year as a new subcohort and thus patients could be included in more than 1 calendar year, if they were hospitalized in different years. We treated each hospitalization as an episode of care and transfers between acute care hospitals were counted as being the same episode with the length of stay incorporating time at both hospitals (but attributed to the hospital the patient was eventually discharged from). We excluded those hospitalizations in which the patient was discharged to a rehabilitation hospital. For those patients with multiple hospitalizations in any 1 calendar year, we randomly selected 1 episode of care in that year for this analysis, as per prior studies in this area. 2 In a sensitivity analysis, we restricted the analysis to only those patients with an incident (first time) hospitalization for HF and excluded their subsequent hospitalizations, even if they were in different study years.
Covariates
Comorbidities for each patient were identified using the Discharge Abstract database for the index hospitalization and any hospitalizations in the 12 months prior to their index admission.
Analyses
Ages and patient comorbidities were calculated per year and compared via linear and Cochran-Armitage trend tests where appropriate. We examined secular trends between 1999 and December 2009 in those outcomes outlined in Table 1 . Our a priori specified primary outcome was all-cause readmission or death in the first 30 days postdischarge, which we chose for 4 reasons. First, there are validated risk adjustment models for this 30-day outcome. [12] [13] [14] Second, this outcome is more closely linked to quality of inpatient care than events during a longer timeframe. 14 Third, as our data ended in December 2009, we would have had to exclude any patients hospitalized after December 2008, if we used 12-month outcomes (substantially reducing the power of our interrupted time series analyses, since the ACA initiative occurred in the spring of 2008). Fourth, given the recent proposal within the Affordable Care Act to penalize hospitals with high 30day readmission rates, there is now substantial interest in evaluating events in this timeframe.
For comparisons of 30-day mortality rates and postdischarge readmission rates over time, we adjusted for covariates included in the Centers for Medicare & Medicaid Services-endorsed models for these outcomes. 12, 13 For analyses of 30-day postdischarge mortality or readmission rates, we adjusted for covariates included in a recently described risk-prediction model for this outcome (the LACE model), which, importantly, incorporates index hospitalization length of stay. 14 To examine the impact of the ACA initiative (which was implemented in April and May 2008), we conducted interrupted time series analyses by comparing rates for each outcome in those patients discharged with HF after June 2008 (defined as post-ACA), with those discharged during the baseline (April 1999-March 2008) cohort (defined as pre-ACA) using autoregressive, integrated, moving average models. Autocorrelation, partial autocorrelation, and inverse autocorrelation functions were assessed for model-parameter appropriateness and seasonality. Stationarity was assessed using the autocorrelation function and the augmented Dickey-Fuller test. The presence of white noise was assessed by examining the autocorrelations at various lags, using the Ljung-Box X 2 statistic.
In a preplanned subgroup analysis, we compared the impact of the ACA initiative in regions identified as ACA vanguard sites (ie, those where access to specialized HF clinics was enhanced via establishment of new clinics or expansion of capacity in existing clinics) compared with others (as defined by the operational team of the ACA, independently of this evaluation, based on distribution of funding and data on patient referrals and follow-up visits after May 2008). Full details of the various operational changes across the province of Alberta are included in the Alberta Cardiac Access Collaborative Final Evaluation Report of May 2009 available at http://www.cardiacaccess.ab.ca/evaluation.aspx. All statistical analyses were done using SAS version 9.3 (Cary, NC) and R version 2.15.1 (Vienna, Austria).
Results
During our study timeframe, there were 46 396 adult hospitalizations with HF, as the most responsible diagnosis. After randomly selecting one most responsible diagnosis HF hospitalization per patient, our cohort included 37 891 hospitalizations between 1999 and 2009 ( Figure 1 )-26 581 of these hospitalizations were incident hospitalizations in patients with a new diagnosis of HF.
Patients hospitalized with a most responsible diagnosis of HF were generally similar across study years, although age and comorbidity burden increased significantly between 1999 and 2009 (Table 1) , including in those patients with incident HF hospitalization ( Table I in the online-only Data Supplement). In particular, the proportion of HF patients with diabetes (from 30.7% to 40.3%), atrial fibrillation (from 37.7% to 49.2%), chronic renal disease (from 16.7% to 26.9%), or dementia (from 5.4% to 10.4%) increased substantially (all P<0.01), whereas the proportion with prior myocardial infarction decreased substantially (from 30.6% to 20.6%; P<0.01). Of note, the total number of diagnosis codes entered into the Discharge Abstract database for patients hospitalized in Alberta during the past decade increased minimally from a mean of 8.72 (SD 4.17) per hospitalization in 1999 to 9.09 (SD 4.81) in 2009.
During the 11 years we studied, we observed several trends in outcomes (Table 2 ). For example, between 1999 and 2009, median length of stay increased from 8 days to 10 days (Table   2 ; P<0.01), in-hospital mortality increased from 8.9% to 13.5% (P<0.01), 30-day mortality increased from 9.1% to 11.5% (P<0.001), and 1-year mortality increased from 29.4% to 36.7% (P<0.001). Trends were virtually identical in analyses restricted to incident HF hospitalizations ( Table II in the online-only Data Supplement). However, these changes reflected the increasing age and comorbidity burden of patients admitted with HF over time: for example, the adjusted Risk Ratio for 30-day mortality was 0.99, 95% confidence interval (CI) 0.86 to 1.15, in 2009 versus 1999, 13 and the adjusted Risk Ratio for all-cause readmission at 30 days was 0.92, 95% CI 0.80 to 1.04, in 2009 versus 1999. 12 The rate of our primary composite outcome of death or all-cause readmission within 30 days of discharge was similar throughout the decade (20.1% in 2009 compared with 20.7% in 1999; adjusted Risk Ratio, 0.91; 95% CI, 0.82-1.01, using an adjustment model which included index hospital length of stay), 14 with expected seasonal variations in that event rates were higher each winter and lower each summer ( Figure 2 ), except 2009, when the H1N1 epidemic occurred in the summer. Results were very similar in the sensitivity analysis restricted to incident HF hospitalizations: 30-day death or readmission rates decreased minimally from 20.9% in 1999 to 19.9% in 2009, adjusted Risk Ratio 1.06 (95% CI, 0.95-1.18) using the risk-adjustment model that included length of stay during the index hospitalization (Table  II in the online-only Data Supplement). Of note, HF was the most responsible diagnosis in less than one-third of readmissions (ranging from 5.3% in 1999 to 5.4% in 2008/2009; Values are frequencies (and %) unless otherwise stated. Table 2 ). The majority of patients discharged after a HF hospitalization were reviewed within 30 days by a physician, increasing from 72.1% in 1999 to 78.9% in 2009 (P<0.01).
After accounting for secular trends using interrupted time series analyses (Table 3) , the ACA initiative was not associated with any significant changes in index hospitalization mortality (step change P=0.39 and trend change P=0.30), the proportion of patients seen by an outpatient physician in the first 30 days after discharge (step change P=0.83 and trend change P=0.18), nor the proportion of patients with unplanned emergency room visits in the first 30 days after discharge (step change P=0.75 and trend change P=0.54). However, the ACA initiative was associated with a statistically significant step change (a 10.2% absolute increase; 95% CI, 0.4-20.0%) in specialized clinic visits in the spring of 2008, and a statistically significant trend change in 30-day postdischarge mortality or all-cause readmission rates thereafter (which were increasing 0.3% per month [0.2%-0.3%] pre-ACA and decreased 1.4% per month [0.3%-2.5%] in the 18 months post-ACA; P<0.01).
Our subgroup analysis confirmed that patients discharged from ACA vanguard sites (20 162 of the 33 405 hospital discharges in our cohort) did exhibit a statistically significant and substantial step change in specialized clinic visits (absolute increase in the spring of 2008 of +12.2%; 95% CI, 0.6-23.8%), which was not seen in other areas of Alberta. Moreover, wheras ACA vanguard sites exhibited similar trends in 30-day postdischarge death/readmission rates pre-ACA as other sites (increasing 0.24% per month versus 0.30% per month), only the ACA vanguard sites exhibited a statistically significant reversal in that trend after the spring of 2008 (with a 1.6% per month; 95% CI, 0.6-2.6%, decline during the 18 months postimplementation; Figure 2 ).
After roll out of the ACA initiative, patients hospitalized in ACA vanguard regions exhibited similar rates of index hospitalization mortality (odds ratio, 0.98; 95% CI, 0.82-1.17) and 30-day physician follow-up visits (odds ratio, 1.02; 95% CI, 0.87-1.18), as those hospitalized in other regions. However, they were 40% more likely to receive a specialized clinic visit in the first 30 days after discharge (95% CI, 23-59%), and they exhibited better outcomes than those discharged from other areas in the province: 30-day death/readmission rate after discharge 18.6% versus 22.2%, crude odds ratio 0.80 (95% CI, 0.69-0.93), and after adjustment using the model 17 incorporating index hospitalization length of stay, adjusted odds ratio 0.83 (95% CI, 0.75-0.93).
Discussion
We found substantial changes in length of stay, mortality, and 30-day all-cause readmission rates for hospitalized HF patients during the past decade; however, after adjustment for temporal shifts in patient demographics and comorbidities, none of these changes were statistically significant. More than three-quarters of the patients surviving a hospitalization for HF in Alberta (which has a publicly funded universal access health care system) saw a physician within 30 days of discharge. A province-wide program designed to enhance access to specialized HF clinics was successful in its goal in that there was a 10% absolute increase in the number of patients seen in specialized HF clinics within 30 days of discharge after program implementation. However, it should be acknowledged that even after roll out of the ACA initiative, only a minority of Albertans discharged from hospital with HF are followed in specialized clinics (http://www.cardiacaccess.ab.ca).
The ACA program did not lead to any change in pre-existing secular trends with respect to index hospital mortality or length of stay, and for those patients discharged from hospital there were no appreciable changes in the frequency of outpatient visits with other physicians, emergency departments, or unplanned readmissions for HF pre/post the ACA initiative. However, the ACA initiative was associated with a statistically significant reversal of the upward trend in 30-day postdischarge mortality or all-cause readmission rates observed prior to ACA implementation. This shift in outcomes was only seen in the ACA vanguard regions where access to specialized HF clinics was enhanced. Indeed, patients discharged from vanguard regions exhibited 20% lower rates of death/ readmission in the first 30 days after discharge than those discharged from other Alberta regions.
Our mortality rate in the first 30 days after admission (11.1%) is similar to recent reports from the American Heart Association Get with the Guidelines-Heart Failure registry Table 3 (11%). 3 Although our 30-day postdischarge readmission rates (18%) are lower than the Get with the Guidelines-Heart Failure registry (24.5%), the length of stay in Alberta was substantially longer than in the United States. 3 We were unable to risk adjust the length of stay for year over year comparisons, given the lack of an accurate model for predicting length of stay in HF. 15 We, like prior investigators, 16, 17 found that three-quarters of all readmissions and emergency room visits in patients with HF were for non-HF diagnoses, and we think this justified our decision to focus on all-cause readmissions in our analyses. We chose to focus on a composite outcome of mortality or all-cause readmissions in the first 30 days after discharge, as the correlation between quality of care and discharge planning has been shown to be poor for current Centers for Medicare & Medicaid Services-endorsed outcome measures, when considered as individual events such as 30-day readmission rate or 30-day mortality rate. 18 Although the lack of a measurable impact of the ACA initiative on readmission rates after discharge may be seen as disappointing, we believe this finding is not surprising as readmissions are often a reflection of patient factors (including unremitting progression of disease or comorbidities), socioeconomic factors, the availability of home support and health care resources, and local admission thresholds rather than the quality of care or discharge planning for the target condition. 19, 20 Although we tend to look for errors of omission or commission during their prior hospitalization for patients who return to the emergency room unexpectedly, in reality most readmissions are unavoidable. 21 Although our study reports on a comprehensive list of outcomes in all adults (ie, not just elderly patients) hospitalized with a primary diagnosis of HF in a defined geographic location with universal health coverage, there are some limitations. For one, we relied on administrative data to define HF and comorbidities, and do not have information on ejection fraction, natriuretic peptide levels, nor clinical findings that would delineate severity of illness. However, we used ICD codes and data definition algorithms validated in the same datasets and timeframe as this study 10, 11 to build comorbidity profiles, and the outcomes we evaluated (mortality and all-cause readmissions) are relevant in patients with HF, regardless of left ventricular ejection fraction, pathogenesis, or status. Specialized HF clinics target patients with either systolic or diastolic dysfunction, and there is no evidence to suggest that their efficacy differs by underlying pathogenesis. Although we acknowledge the importance of provider experience in caring for patients with HF, 5, 22 we were unable to examine provider characteristics in our dataset; however, given the relatively stable demographics of the physician workforce in Alberta over the past decade (www. cpsa.ab.ca), it seems unlikely that provider characteristics differed substantially pre/post-ACA implementation in the spring of 2008. Although some may criticize our focus on hard outcomes such as mortality or readmission rather than process of care outcomes, such as medication prescriptions or left ventricular ejection fraction measurements, we would counter that most current process of care measures do not accurately predict patient-relevant morbidity and mortality outcomes. [23] [24] [25] Although there has been a gradual increase in the number of codes entered into the Discharge Abstract database for patients hospitalized in Alberta during the past decade (from a mean of 8.72 in 2000 to 9.09 in 2009 in this cohort), we do not think this is sufficiently large to account for the shifts we observed in the comorbidity profiles of our hospitalized cohort-indeed, recent reports from the Olmsted County cohort study, the National Health and Nutrition Examination Surveys, and the OPTIMIZE-HF registry (none of which used administrative records) also documented similar increases in comorbidities in incident HF patients over time, with prevalences of diabetes mellitus, hypertension, atrial arrythmias, and renal disease, close to those we found. [26] [27] [28] Finally, we were limited to studying pathogenetic associations in this study, as the administrative data provided by Alberta Health was deidentified both at the level of the patient and the practitioner, and thus we were unable to specifically compare outcomes in patients seen in specialized clinics with the other HF patients discharged in the province. However, the focus of our study was not to evaluate the effects of specialized clinics (as there is already ample randomized clinical trial evidence proving their efficacy), 6 but rather to examine whether a province-wide initiative to increase access to such clinics would have a measurable impact on outcomes.
. Outcomes in Patients With Most Responsible Diagnosis of HF Before and After the Changes to HF Service Delivery in Alberta
In summary, a province-wide initiative increasing the proportion of patients with HF managed in specialized clinics after discharge resulted in improved outcomes after discharge (lower 30-day death/readmission rates) without impacting health resource use in other areas, such as outpatient physician or emergency department visits. Thus, jurisdictions looking to improve postdischarge outcomes in patients with HF should consider implementing programs similar to the ACA initiative. Although the ACA initiative targeted patients with HF discharged from a hospital, we have previously 29 shown that almost two-thirds of Albertans with HF had their incident diagnosis made in the emergency department or an outpatient clinic. Thus, we would suggest that future iterations of initiatives such as the ACA should target patients with HF diagnosed in all settings, rather than waiting until an index hospitalization.
